SCHEDULE 13G/A
Statement of Beneficial Ownership
Ascendis Pharma A/S Filed Acc 0001897612-26-000734
Stakes reported in this filing
| Reporting person | Shares | Of the class |
|---|---|---|
| T. Rowe Price Investment Management, Inc. | 8,194,812 | 12.4% |
Members of a group can each report the same shares, so these rows overlap and don't add up.
Loading xslSCHEDULE_13G_X02/primary_doc.xml…